The antiapoptotic protein ICBP90 is a target for protein kinase 2

Annals of the New York Academy of Sciences

Volumn 1030, Issue , 2004, Pages 355-360

  Bronner, Christian ^a   Trotzier, Marie Aline ^a   Filhol, Odile ^b   Cochet, Claude ^b   Rochette Egly, Cécile ^b   Schöller Guinard, Marie ^a   Klein, Jean Paul ^a   Mousli, Marc ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSERM   (France)

Author keywords

Apoptosis; Cancer; Cell proliferation; CK2; ICBP90

Indexed keywords

CASEIN KINASE II; PROTEIN KINASE 2; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ICBP90; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; CANCER; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME SUBSTRATE; ENZYME SUBUNIT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TRANSCRIPTION REGULATION;

EID: 15044339441     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1329.044     Document Type: Conference Paper

References (17)

1. KAUFMANN, S.H. & G.J. GORES. 2000. Apoptosis in cancer. Bioessays 22: 1007-1017.
2. BRONNER, C., R. HOPFNER & M. MOUSLI. 2002. Transcriptional regulation of the topoisomerase IIα gene. Anticancer Res. 22: 605-612.
3. HOPFNER, R., M. MOUSLI, J.M. JELTSCH, et al. 2000. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIa expression. Cancer Res. 60: 121-128.
4. ABBADY, A.Q., C. BRONNER, M.A. TROTZIER, et al. 2003. ICBP90 expression is downregulated in apoptosis-induced Jurkat cells. Ann. N.Y. Acad. Sci. 1010: 300-303.
5. MOUSLI, M., R. HOPFNER, A.Q. ABBADY, et al. 2003. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Br. J. Cancer 89: 120-127.
6. AHMED, K., A. GERBER & C. COCHET. 2002. Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol. 12: 226-230.
7. LANDESMAN-BOLLAG, E., P.L. CHANNAVAJHALA, R.D. CARDIFF, et al. 1998. p53 deficiency and misexpression of protein kinase CK2α collaborate in the development of thymic lymphomas in mice. Oncogene 16: 2965-2974.
8. Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Gene Cells 9: 131-142.
9. LEBRIN, F., E.M. CHAMBAZ & L. BIANCHINI. 2001. A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit α. Oncogene 20: 2010-2022.
10. HANNA, D.E., A. RETHINASWAMY & C.V. GLOVER. 1995. Casein kinase II is required for cell cycle progression during G1 and G2/M in Saccharomyces cerevisiae. J. Biol. Chem. 270: 25905-25914.
11. ROCHETTE-EGLY, C., M. OULAD-ABDELGHANI, A. STAUB, et al. 1995. Phosphorylation of the retinoic acid receptor-α by protein kinase A. Mol. Endocrinol. 9: 860-871.
12. BOYLE, W.J., P. VAN DER GEER & T. HUNTER. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201: 110-149.
13. BIEKER, J.J., L. OUYANG & X. CHEN. 1998. Transcriptional factors for specific globin genes. Ann. N.Y. Acad. Sci. 850: 64-69.
14. ARMSTRONG, S.A., D.A. BARRY, R.W. LEGGETT, et al. 1997. Casein kinase II-mediated phosphorylation of the C terminus Sp1 decreases its DNA binding activity. J. Biol. Chem. 272: 13489-13495.
15. TSUTSUI, H., C. GELTINGER, T. MURATA, et al. 1999. The DNA-binding and transcriptional activities of MAZ, a myc-associated zinc finger protein, are regulated by casein kinase II. Biochem. Biophys. Res. Commun. 262: 198-205.
16. MÜLLER, H. & K. HELLIN. 2000. The E2F transcription factors: key regulators of cell proliferation. Biochim. Biophys. Acta 1470: M1-M12.
17. MORI, T., Y. LI, H. HATA, et al. 2004. NIRF is a ubiquitin ligase that is capable of ubiquitinating PCNP, a PEST-containing nuclear protein. FEBS Lett. 559: 209-214.